Corporate report: Patient and Public Involvement and Engagement Plan 2026-2030
Safety Classified by Officially
The Medicines and Healthcare products Regulatory Agency (MHRA) is committed to putting patients and the public at the heart of our work. This plan sets out our approach to patient and public involvement and engagement from 2026 to 2030. It builds on the progress made through our Patient Involvement Strategy 2021-2025.
The plan explains how we will involve patients, carers and the wider public in regulatory decisions. This includes medicines safety, medical devices and emerging technologies. It outlines our principles for inclusive engagement, transparency and collaboration, and how we will ensure a broader range of voices and experiences inform our work.
It also sets out our priorities and planned activities over the next three years, including:
This is an extract. The publication continues at the source.
Contains public sector information licensed under the Open Government Licence v3.0. Licence
Read the original at the source: https://www.gov.uk/government/publications/patient-and-public-involvement-and-engagement-plan-2026-2030
Officially imported this from Medicines and Healthcare products Regulatory Agency’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.
Provenance
- Organization
- Medicines and Healthcare products Regulatory Agency — imported from official source
- Official source
- https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency.atom ATOM
- Imported
- November 05, 2026 17:02
- Versions
- 1 recorded
- Identity
-
https://www.gov.uk/government/publications/patient-and-public-involvement-and-engagemen...